-

Drug Discovery Informatics Strategic Business Report 2023-2030: Growing Demand for Efficient Drug Development Processes Drives Growth, Expansion of Genomics and Proteomics Research Spurs Demand - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drug Discovery Informatics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Drug Discovery Informatics was estimated at US$2.5 Billion in 2023 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

This report offers key insights into the Global Drug Discovery Informatics Market, highlighting the strong growth trajectory of the Software Component segment, which is projected to reach US$3 billion by 2030 with a CAGR of 7.9%. The Services Component segment is also expected to grow significantly, at a 9.5% CAGR over the next eight years.

The report provides a detailed regional analysis, noting that the U.S. market is estimated at $744.5 million in 2023, while China is forecasted to grow at a robust 7.9% CAGR, reaching $824.6 million by 2030. Additionally, growth trends in other key regions such as Japan, Canada, Germany, and the Asia-Pacific are explored.

Reasons to purchase this report include access to a thorough market analysis, competitive insights, an understanding of future trends and drivers, and actionable insights for identifying new revenue opportunities. The report features comprehensive market data with independent analysis of annual sales and market forecasts from 2023 to 2030, in-depth regional analysis, and company profiles of major players like Certara USA, Inc., Charles River Laboratories International, Inc., and Collaborative Drug Discovery, Inc. Furthermore, buyers will receive complimentary updates for one year to stay informed of the latest market developments.

Key Questions Answered:

  • How is the Global Drug Discovery Informatics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Key Attributes:

Report Attribute Details
No. of Pages 188
Forecast Period 2023 - 2030
Estimated Market Value (USD) in 2023 $2.5 Billion
Forecasted Market Value (USD) by 2030 $4.8 Billion
Compound Annual Growth Rate 8.4%
Regions Covered Global

Key Topics Covered:

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Drug Discovery Informatics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

MARKET TRENDS & DRIVERS

  • Growing Demand for Efficient Drug Development Processes Drives Growth in Drug Discovery Informatics Market
  • Advances in Computational Biology and AI Propel Adoption of Drug Discovery Informatics Solutions
  • Expansion of Genomics and Proteomics Research Spurs Demand for Drug Discovery Informatics Tools
  • Technological Innovations in High-Throughput Screening Set the Stage for Market Growth in Drug Discovery Informatics
  • Expansion of Informatics Solutions in Clinical Trials and Drug Development Spurs Demand for Advanced Tools
  • Technological Innovations in Molecular Modeling and Simulation Propel Adoption in Drug Discovery Informatics
  • Advances in Cloud-Based and SaaS Informatics Platforms Propel Growth in Collaborative Drug Development

FOCUS ON SELECT PLAYERS (Total 29 Featured)

  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/y2kd25

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom